Competitive and Mutant Probe EMSA Service
Specificity Assessment for EMSA Results
CD BioSciences provides Competitive EMSA and Mutant Probe Validation services to help evaluate whether a shifted EMSA band is related to a specific DNA or RNA sequence. The service can be applied to plant transcription factor-DNA binding assays, RNA-binding protein studies, and other plant protein-nucleic acid interaction projects.
Competition experiments are especially useful when a validation EMSA shows a shifted band but additional evidence is required to distinguish sequence-specific binding from non-specific probe retention or background protein binding.
Principle
In competitive EMSA, an excess amount of unlabeled competitor probe is added to the binding reaction. If the shifted band is reduced by unlabeled wild-type competitor but not by a mutant or unrelated competitor, the result supports sequence-related binding. The design does not replace biological validation, but it provides important biochemical evidence for binding specificity.
Figure 1. Competitor probe design for evaluating sequence-specific binding in EMSA.
Competitor Probe Types
| Probe Type | Purpose |
|---|---|
| Unlabeled wild-type competitor | Tests whether excess unlabeled target sequence can compete with the labeled probe for protein binding. |
| Mutant competitor | Tests whether disruption of the candidate binding motif reduces competitive ability. |
| Non-specific competitor | Helps evaluate whether the protein binds broadly to unrelated nucleic acid sequences. |
| Labeled mutant probe | Can be used when direct comparison between wild-type and mutant labeled probes is required. |
Experimental Design
The design may include a fixed concentration of protein and labeled probe, followed by competitor probes at selected molar excess ratios. Common designs include 25-fold, 50-fold, or 100-fold excess competitor, although the final ratio depends on probe length, protein concentration, binding strength, and signal intensity.
Figure 2. Representative competitive EMSA lane interpretation using wild-type, mutant, and non-specific competitors.
A reduction in shifted band intensity with wild-type competitor should be interpreted together with mutant competitor, non-specific competitor, free probe, and protein-only context. Band disappearance alone is not sufficient if control lanes are missing.
Applications
- Validation of predicted transcription factor binding motifs
- Comparison of wild-type and mutant promoter sequences
- Specificity assessment for RNA-binding protein targets
- Reduction of false-positive EMSA interpretation
- Support for promoter regulation or RNA-protein interaction studies
- Follow-up validation after initial EMSA band detection
Information Required
- Original labeled probe sequence
- Candidate binding motif or mutation plan, if available
- Target protein information and sample source
- Existing EMSA result, if this is a follow-up project
- Expected competitor ratios or required experimental groups
- Relevant references or motif prediction data
Deliverables
- Competitor and mutant probe design information
- Probe synthesis and labeling information, if applicable
- Experimental lane design and assay record
- Original and processed gel images, if required
- Specificity-focused data interpretation
- Standard experimental report
Related Services
Please contact us with your probe sequence, target motif, protein sample information, and intended competitor design for project evaluation.
For research use only, not for clinical use.